Joining over 50 existing cases, another lawsuit has been filed alleging anti-nausea drug Zofran (ondansetron) was responsible for causing birth defects. The complaint contends that GlaxoSmithKline (“GSK”) marketed Zofran (ondansetron) “off label,” even though it was only approved for use by the FDA for treatment of severe nausea and vomiting in cancer patients or those who underwent major surgery. The plaintiff, an Alabama mother, claims that the drug caused her daughter’s severe heart defects, requiring the child to undergo invasive surgery when she was only eight months old.
Plaintiffs’ firm Grant & Eisenhofer is a leader in filing similar cases against GSK, and in fact, filed the first case in the litigation. If you or a loved one took Zofran (ondansetron) for morning sickness and your child was born with a congenital heart defect or cleft palate, you may be entitled to compensation. Call us today at 877-978-0169 for a free, confidential legal consultation of your potential claim.